Literature DB >> 338057

Purification and characterization of granulocytic progenitor cells (CFU-C) from human peripheral blood using immunologic surface markers.

C M Richman, L Chess, R A Yankee.   

Abstract

The concentration of committed granulocytic progenitor cells (CFU-C) in functionally unique subpopulations of human peripheral blood mononuclear cells has been determined by the in vitro methyl-cellulose assay. Using immunoabsorbent column chromatography and rosette-depletion techniques, we have demonstrated that CFU-C, although not present in either purified T or B lymphocyte populations, are highly concentrated in the "null" cell population, which lacks sheep erythrocyte receptors and surface immunoglobulin. Further fractionation of this null subset has demonstrated that CFU-C do not bear complement receptors, but require the presence of peripheral blood mononuclear cell feeder layers for maximum proliferation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 338057

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

1.  Oxpentifylline and cetiedil citrate improve deformability of dehydrated sickle cells.

Authors:  J Stuart; P C Stone; Y Y Bilto; A J Keidan
Journal:  J Clin Pathol       Date:  1987-10       Impact factor: 3.411

Review 2.  Haemopoietic progenitor cells in peripheral blood.

Authors:  F E Zwaan
Journal:  Blut       Date:  1982-08

3.  Transforming growth factor beta inhibits formation of osteoclast-like cells in long-term human marrow cultures.

Authors:  C Chenu; J Pfeilschifter; G R Mundy; G D Roodman
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

4.  Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures.

Authors:  N Takahashi; B R MacDonald; J Hon; M E Winkler; R Derynck; G R Mundy; G D Roodman
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.